Skip to main content
TipRanks
Go Ultimate75% OFF

Suven Life Sciences Limited (SUVEN) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Suven Life Sciences Limited has a market cap or net worth of INR 78.67B. The enterprise value is INR 87.11B.

Market Cap
INR 78.67B
Enterprise Value
INR 87.11B

Share Statistics

Suven Life Sciences Limited has 282,562,680 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
282,562,680
Owned by Insiders
―
Owned by Institutions
0.02%

Financial Efficiency

Suven Life Sciences Limited’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -47.56%.

Return on Equity (ROE)
-0.47
Return on Assets (ROA)
-0.44
Return on Invested Capital (ROIC)
-47.56%
Return on Capital Employed (ROCE)
-0.49
Revenue Per Employee
504.59K
Profits Per Employee
-19.60M
Employee Count
141
Asset Turnover
0.01
Inventory Turnover
480.81

Valuation Ratios

The current PE Ratio of Suven Life Sciences Limited is -23.74. Suven Life Sciences Limited’s PEG ratio is 0.81.

PE Ratio
-23.74
PS Ratio
694.65
PB Ratio
17.25
Price to FCF
-59.86
Price to Operating Cash Flow
-75.68
PEG Ratio
0.81

Income Statement

In the last 12 months, Suven Life Sciences Limited had revenue of 71.15M and earned -2.76B in profits. Earnings per share was -12.13.

Revenue
71.15M
Gross Profit
-419.28M
Operating Income
-2.90B
Pretax Income
-2.76B
Net Income
-2.76B
EBITDA
-2.71B
Earnings Per Share (EPS)
-12.13

Cash Flow

In the last 12 months, operating cash flow was -1.03B and capital expenditures -21.37M, giving a free cash flow of -1.06B billion.

Operating Cash Flow
-1.03B
Free Cash Flow
-1.06B
Free Cash Flow per Share
-3.74

Dividends & Yields

Suven Life Sciences Limited pays an annual dividend of INR 1.38, resulting in a dividend yield of ―

Dividend Per Share
INR 1.38
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1.67%
Earnings Yield
-3.73%

Stock Price Statistics

Beta
1.50
52-Week Price Change
52.26%
50-Day Moving Average
304.27
200-Day Moving Average
258.70
Relative Strength Index (RSI)
47.03
Average Volume (3m)
48.24K

Important Dates

Suven Life Sciences Limited upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 14, 2027
Ex-Dividend Date
Feb 14, 2019

Financial Position

Suven Life Sciences Limited as a current ratio of 17.69, with Debt / Equity ratio of 2.82%

Current Ratio
17.69
Quick Ratio
17.69
Debt to Market Cap
0.00
Net Debt to EBITDA
1.19
Interest Coverage Ratio
-1838.51

Taxes

In the past 12 months, Suven Life Sciences Limited has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Suven Life Sciences Limited EV to EBITDA ratio is -21.71, with an EV/FCF ratio of -59.79.

EV to Sales
693.76
EV to EBITDA
-21.71
EV to Free Cash Flow
-59.79
EV to Operating Cash Flow
-61.02

Balance Sheet

Suven Life Sciences Limited has INR 5.18B in cash and marketable securities with INR 166.94M in debt, giving a net cash position of INR 5.01B billion.

Cash & Marketable Securities
INR 5.18B
Total Debt
INR 166.94M
Net Cash
INR 5.01B
Net Cash Per Share
INR 17.75
Tangible Book Value Per Share
INR 26.19

Margins

Gross margin is -331.69%, with operating margin of -3455.63%, and net profit margin of -3205.79%.

Gross Margin
-331.69%
Operating Margin
-3455.63%
Pretax Margin
-3205.79%
Net Profit Margin
-3205.79%
EBITDA Margin
-3195.30%
EBIT Margin
-3276.53%

Analyst Forecast

The average price target for Suven Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
55.10%
EPS Growth Forecast
-50.35%

Scores

Smart Score
―
AI Score
43